Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells <i>in vitro</i>.

Front Immunol · 2023 · PMC10593434 · PMID 37876933

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

showed a trendp=0.071so close (0.05 < p ≤ 0.1)

low expressors, only in the group of CD47 low expressors showed a trend towards the negative impact of high CD163 expression on overall survival was observed ( Figure 4H , Supplementary Figure 4A ; p=0.071 and p=0.687).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.